High PD-L1 expression in ccRCC is associated with poorer overall survival (OS), as well as decreased DFS, progression-free survival (PFS), and DSS [24, 93–95, 99, 100]. The gene discussed is CD274; the disease is nonpapillary renal cell carcinoma.